Dual-time-point (18)F-FDG-PET/CT imaging in the assessment of suspected malignancy

Chan, Wai-Ling, Ramsay, Stuart C., Szeto, Edwin R., Freund, Judith, Pohlen, Judith M., Tarlinton, Lisa C., Young, Andy, Hickey, Adam, and Dura, Robert (2011) Dual-time-point (18)F-FDG-PET/CT imaging in the assessment of suspected malignancy. Journal of Medical Imaging and Radiation Oncology, 55 (4). pp. 379-390.

[img] PDF (Published Version) - Published Version
Restricted to Repository staff only

View at Publisher Website: http://dx.doi.org/10.1111/j.1754-9485.20...
 
14
1


Abstract

Introduction (purpose of the study): The objective of this study was to assess whether dual-time-point ¹⁸F-fluoro-2-deoxyglucose (¹⁸F-FDG)-PET/CT imaging improved the evaluation of suspected malignancy and if there was any resulting change in management.

Methods: A total of 53 patients with suspected malignancy were investigated by performing two static acquisitions started at mean times t = 64 and t = 155 min after the tracer injection. The total number of malignant lesions was 133 and the total number of benign lesions was 61. Visual and semiquantitative analysis was performed on both the early and delayed images.

Results: Overall, there was a significant improvement (P < 0.001) in the sensitivity of delayed imaging (94%) compared with early imaging (77%) in detecting malignant lesions, without a reduction in specificity. In 10 patients, 13 malignant lesions were undetected on early imaging alone but detected on delayed imaging. In seven patients, 10 malignant lesions were incorrectly classified as 'likely benign' on early imaging but correctly reported as 'likely malignant' on delayed imaging. Management was altered in 2 out of 17 patients. Overall, delayed imaging altered management in 2 out of 53 studied patients. Dual-time-point ¹⁸FDG-PET/CT imaging was useful in differentiating malignant from benign intra-abdominal lesions but did not improve the evaluation of pulmonary lesions.

Conclusions:¹⁸F-FDG-PET/CT imaging should be performed as late as reasonably possible after tracer administration in order to increase tumour-to-background contrast and thereby improve the sensitivity of demonstrating additional sites of disease. Dual-time-point ¹⁸FDG-PET/CT may be of benefit in the evaluation of intra-abdominal lesions but does not improve the overall evaluation of pulmonary lesions.

Item ID: 24811
Item Type: Article (Research - C1)
ISSN: 1754-9485
Keywords: 18F-FDG-PET/CT; dual-time-point imaging; malignancy; sensitivity; standardised uptake value (SUV)
Date Deposited: 08 May 2013 02:06
FoR Codes: 11 MEDICAL AND HEALTH SCIENCES > 1112 Oncology and Carcinogenesis > 111202 Cancer Diagnosis @ 100%
SEO Codes: 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920102 Cancer and Related Disorders @ 100%
Downloads: Total: 1
More Statistics

Actions (Repository Staff Only)

Item Control Page Item Control Page